Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLRD
5151
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $174K | ﹤0.01% |
30,200
+12,600
| +72% | +$87.4K |
|
5152
Allient
ALNT
$1.61B
| $173K | ﹤0.01% |
6,841
+3,306
| +94% | +$79.2K |
|
5153
CALL
Chemours
CC
$2.24B
| $173K | ﹤0.01% |
7,200
-20,800
| -74% | -$613K |
|
5154
ALPS Strategic Income Fund
RIGS
$60.4M
| $173K | ﹤0.01% |
7,000
| – | – |
|
|
KDMN
5155
DELISTED
Kadmon Holdings, Inc.
KDMN
| $173K | ﹤0.01% |
83,937
+41,471
| +98% | +$92.3K |
|
|
ROAN
5156
DELISTED
Roan Resources, Inc.
ROAN
| $173K | ﹤0.01% |
99,593
-3,747
| -4% | -$13.5K |
|
5157
CALL
Cameco
CCJ
$41.1B
| $172K | ﹤0.01% |
16,000
+4,600
| +40% | +$49.5K |
|
5158
PUT
Fidelity National Information Services
FIS
$22.2B
| $172K | ﹤0.01% |
1,400
-100
| -7% | -$11.7K |
|
5159
Floor & Decor
FND
$6.6B
| $172K | ﹤0.01% |
4,101
+2,443
| +147% | +$102K |
|
5160
National Bankshares
NKSH
$264M
| $172K | ﹤0.01% |
4,404
+2,334
| +113% | +$93.1K |
|
5161
PUT
Packaging Corp of America
PKG
$22.9B
| $172K | ﹤0.01% |
1,800
-11,800
| -87% | -$1.14M |
|
5162
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
| $172K | ﹤0.01% |
1,600
-100
| -6% | -$10.6K |
|
|
CHMA
5163
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $171K | ﹤0.01% |
22,985
-16,915
| -42% | -$111K |
|
5164
CALL
Charles River Laboratories
CRL
$12.5B
| $170K | ﹤0.01% |
1,200
| – | – |
|
|
GNTY
5165
DELISTED
Guaranty Bancshares
GNTY
| $170K | ﹤0.01% |
6,027
+3,409
| +130% | +$89.8K |
|
5166
Lexicon Pharmaceuticals
LXRX
$1.08B
| $170K | ﹤0.01% |
27,054
+10,944
| +68% | +$65.5K |
|
5167
Mistras Group
MG
$504M
| $170K | ﹤0.01% |
11,827
+2,768
| +31% | +$38.1K |
|
5168
CALL
Papa John's
PZZA
$978M
| $170K | ﹤0.01% |
3,800
-4,600
| -55% | -$227K |
|
5169
Global Indemnity Group
GBLI
$418M
| $169K | ﹤0.01% |
5,448
+2,663
| +96% | +$80.5K |
|
5170
HF Foods Group
HFFG
$78.1M
| $169K | ﹤0.01% |
+4,849
| New | +$78.5K |
|
|
IPG
5171
CALL
DELISTED
Interpublic Group of Companies
IPG
| $169K | ﹤0.01% |
7,500
-127,900
| -94% | -$2.84M |
|
5172
CALL
Euronet Worldwide
EEFT
$2.87B
| $168K | ﹤0.01% |
1,000
+600
| +150% | +$91.7K |
|
|
SNV
5173
PUT
DELISTED
Synovus
SNV
| $168K | ﹤0.01% |
4,800
-20,000
| -81% | -$695K |
|
|
MDCO
5174
PUT
DELISTED
Medicines Co
MDCO
| $168K | ﹤0.01% |
4,600
-78,500
| -94% | -$2.56M |
|
|
MAG
5175
DELISTED
MAG Silver
MAG
| $167K | ﹤0.01% |
15,800
-92,438
| -85% | -$927K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.